Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Chem Biodivers ; 18(10): e2100493, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34403573

ABSTRACT

Hundreds of millions of people worldwide are affected by Chagas' disease caused by Trypanosoma cruzi. Since the current treatment lack efficacy, specificity, and suffers from several side-effects, novel therapeutics are mandatory. Natural products from endophytic fungi have been useful sources of lead compounds. In this study, three lactones isolated from an endophytic strain culture were in silico evaluated for rational guidance of their bioassay screening. All lactones displayed in vitro activity against T. cruzi epimastigote and trypomastigote forms. Notably, the IC50 values of (+)-phomolactone were lower than benznidazole (0.86 vs. 30.78 µM against epimastigotes and 0.41 vs. 4.88 µM against trypomastigotes). Target-based studies suggested that lactones displayed their trypanocidal activities due to T. cruzi glyceraldehyde-3-phosphate dehydrogenase (TcGAPDH) inhibition, and the binding free energy for all three TcGAPDH-lactone complexes suggested that (+)-phomolactone has a lower score value (-3.38), corroborating with IC50 assays. These results highlight the potential of these lactones for further anti-T. cruzi drug development.


Subject(s)
Biological Products/pharmacology , Euphorbia/chemistry , Lactones/pharmacology , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Biological Products/chemistry , Biological Products/metabolism , Euphorbia/metabolism , Lactones/chemistry , Lactones/metabolism , Models, Molecular , Molecular Structure , Parasitic Sensitivity Tests , Phylogeny , Trypanocidal Agents/chemistry , Trypanocidal Agents/metabolism
2.
Chem Biol Drug Des ; 80(4): 561-71, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22702225

ABSTRACT

The drugs against tropical neglected diseases, especially Chagas' Disease, were launched more than 30 years ago, and the development of resistance requires the discovery of new and more effective chemotherapeutic agents. Trypanosoma cruzi has a redox enzyme called trypanothione reductase which was successfully inhibited for peptide derivatives (McKie et al., Amino Acids, 2001, 20: 145). This work aims at studying the mechanism of inhibition of this enzyme through molecular dynamics simulations and evaluating the behavior of some derivatives when inhibiting this protein. We should affirm that any particular molecular dynamics analysis tools (Hbond pattern, 3-D root-mean-square deviation, solvent accessible surface area, etc.) cannot be used apart from the others to justify completely these peptides inhibitory patterns. Based on our results, we reproduced the experimental data and, moreover, we discriminated against a new site in enzyme aperture, which can assist the development of powerful inhibitors against trypanothione reductase enzyme.


Subject(s)
NADH, NADPH Oxidoreductases/metabolism , Peptides/chemistry , Peptides/pharmacology , Trypanocidal Agents/chemistry , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/enzymology , Catalytic Domain , Chagas Disease/drug therapy , Chagas Disease/enzymology , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Humans , Hydrogen Bonding , Molecular Docking Simulation , NADH, NADPH Oxidoreductases/chemistry , Trypanosoma cruzi/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...